
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Amplia Therapeutics is a biotechnology business based in Australia. Amplia Therapeutics shares (ATX) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Amplia Therapeutics has a trailing 12-month revenue of around $2 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Amplia Therapeutics
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Amplia Therapeutics. Find the share by name or ticker symbol: ATX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Amplia Therapeutics reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Amplia Therapeutics. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
US stocks

Our top pick for
Overall broker

Our top pick for
Low-cost broker

What's in this guide?
- Amplia Therapeutics key stats
- Compare share trading platforms
- Is Amplia Therapeutics stock a buy or sell?
- Amplia Therapeutics performance over time
- Amplia Therapeutics's financials
- How volatile are Amplia Therapeutics shares?
- Does Amplia Therapeutics pay a dividend?
- Have Amplia Therapeutics shares ever split?
- Other common questions
Amplia Therapeutics stock price (ASX:ATX)
Use our graph to track the performance of ATX stocks over time.Amplia Therapeutics shares at a glance
52-week range | $0.09 - $0.25 |
---|---|
50-day moving average | $0.1176 |
200-day moving average | $0.1579 |
Target price | $0.73 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.025 |
Compare share trading platforms
Is it a good time to buy Amplia Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Amplia Therapeutics price performance over time
Historical closes compared with the last close of A$0.096
1 week (2022-06-24) | -2.04% |
---|---|
1 month (2022-06-02) | -26.15% |
3 months (2022-04-01) | -31.43% |
6 months (2021-12-31) | -41.82% |
1 year (2021-07-02) | -57.33% |
---|---|
2 years (2020-07-02) | -16.96% |
3 years (2019-07-02) | 1.05% |
5 years (2017-06-30) | -98.45% |
Amplia Therapeutics financials
Revenue TTM | $2 million |
---|---|
Gross profit TTM | $1.8 million |
Return on assets TTM | -12.88% |
Return on equity TTM | -22.64% |
Profit margin | -183.74% |
Book value | 0.113 |
Market capitalisation | $20.4 million |
TTM: trailing 12 months
Amplia Therapeutics share dividends
We're not expecting Amplia Therapeutics to pay a dividend over the next 12 months.
Have Amplia Therapeutics's shares ever split?
Amplia Therapeutics's shares were split on a 1:10 basis on 30 April 2018. So if you had owned 10 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Amplia Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Amplia Therapeutics shares which in turn could have impacted Amplia Therapeutics's share price.
Amplia Therapeutics share price volatility
Over the last 12 months, Amplia Therapeutics's shares have ranged in value from as little as $0.09 up to $0.25. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Amplia Therapeutics's is 0.4907. This would suggest that Amplia Therapeutics's shares are less volatile than average (for this exchange).
Amplia Therapeutics overview
Amplia Therapeutics Limited, a pharmaceutical company, focuses on development of focal adhesion kinase (FAK) inhibitors for oncology and chronic fibrosis in Australia. The company's product pipeline includes AMP945, an inhibitor of FAK, for pancreatic cancer and idiopathic pulmonary fibrosis, as well as other cancers and fibrotic diseases indications, that has completed Phase I clinical trial; and AMP886 for cancer and fibrotic disease indication. It has a collaboration agreement with the Garvan Institute of Media Research in Sydney. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Stocks similar to Amplia Therapeutics
Amplia Therapeutics in the news
Frequently asked questions
More guides on Finder
-
How to invest in the Australia Sunny Glass Group IPO
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
-
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
-
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
-
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
-
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
Ask an Expert